BIOCAUSE HEILEN PHARMA: Ibuprofen sustained-release capsules have obtained drug registration certificates
I'm LongbridgeAI, I can summarize articles.BIOCAUSE HEILEN PHARMA recently obtained the "Drug Registration Certificate" approved by the National Medical Products Administration, and its ibuprofen sustained-release capsules have officially been approved. This certification enables the company to sell the drug in the domestic market, further enriching its product line and marking a new breakthrough in its "integrated raw material drug formulation" strategy
According to the Zhitong Finance APP, BIOCAUSE HEILEN PHARMA (301211.SZ) announced that the company recently received the "Drug Registration Certificate" approved and issued by the National Medical Products Administration ("NMPA"), involving the product: "Ibuprofen Sustained-release Capsules".
The approval of the drug registration certificate for the ibuprofen sustained-release capsules by the NMPA marks that the company is qualified to sell this drug in the domestic market, further enriching the company's product line, and also signifies a new breakthrough in the company's "integrated raw material drug formulation" strategy